HeyJaredOncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
Medical oncologist Dr Neil Love interviews oncology experts. Free NCPD credit hours are available.
- Indexed episodes, last 90 days
- 9
- Latest publication
- Aug 31, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Prostate Cancer — Proceedings from the 2026 Annual ONS Congress (opens the original)
Read excerpt
Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics: Introduction (0:00) Overview of Prostate Cancer (3:00) Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12) Potential Role of Capivasertib in Metastatic HSPC (27:22) Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39) Current and Future Role of Lutetium Lu 177 Vipivotide Te
Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress (opens the original)
Read excerpt
Featuring perspectives from Ms Caroline Kuhlman, Dr Eileen M O'Reilly, Dr Philip A Philip and Ms Amanda K Wagner, moderated by Dr O'Reilly, including the following topics: Introduction (0:00) Clinical Presentation and Prognosis of Pancreatic Adenocarcinoma (PAD) (3:29) Recent Advances in Up-Front Treatment for Metastatic PAD (15:47) Selection and Sequencing of Therapy for Relapsed/Refractory Metastatic PAD (39:58) Novel Strategies Targeting RAS Mutations in Advanced PAD (48:20) Utility of Tumor
Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress (opens the original)
Read excerpt
Featuring perspectives from Ms Blanca Ledezma, Dr Marissa Marti-Smith, Dr Heather McArthur and Dr Ruth M O'Regan, moderated by Dr McArthur, including the following topics: Introduction (0:00) Current Clinical Role of Oral Selective Estrogen Receptor Degraders (SERDs) in HR-Positive Metastatic Breast Cancer (3:37) Practical Considerations with Oral SERDs (15:42) Potential Role of Combination Approaches with Oral SERDs (26:31) Gastrointestinal Adverse Events Documented with Oral SERDs (38:17) Pote
Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress (opens the original)
Read excerpt
Featuring perspectives from Dr Reva Basho, Ms Kelly Fischer, Ms Melissa Rikal and Dr Seth Wander, moderated by Dr Wander, including the following topics: Introduction (00:00) Identification of Appropriate Candidates for Agents Targeting the PI3K/AKT/mTOR Pathway (3:45) Role of Inavolisib in HR-Positive Metastatic Breast Cancer (mBC) (13:00) Strategies to Prevent and Manage Hyperglycemia (27:02) Clinical Utility of Capivasertib for HR-Positive mBC (38:09) Mitigation and Management of Gastrointest
Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress (opens the original)
Read excerpt
Featuring perspectives from Dr Beth Faiman, Dr Natalie S Callander, Dr Hans Lee and Dr Mary Steinbach, moderated by Dr Callander, including the following topics: Introduction (00:00) Role of Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory (R/R) MM (3:44) Role of BCMA- and Non-BCMA-Targeted Bispecific Antibodies in R/R MM (27:00) Utility of Belantamab Mafodotin in R/R MM (49:29) Potential Role of Cereblon E3 Ligase Modulators in MM (1:07:01) CME information and select publications
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing